This new knowledge permits identification of inherited susceptibility in the preclinical phase and has the potential to identify key targets for new therapeutic interention that will improe health.

• 这些新的知识可以确认临床前期的遗传易感性，也可能确定将改善疾病的新的治疗方法的关键靶标。